Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?
Viruses · 2023
DOI: 10.3390/v15091848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Cassia F Estofolete und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, SP, Brazil. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Influenza, Human, COVID-19, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, São Paulo Research Foundation (FAPESP), INCT Dengue Program.
Abstract (Originalsprache)
Lower respiratory tract infections (LRIs) are a significant cause of disability-adjusted life-years (DALYs) across all age groups, especially in children under 9 years of age, and adults over 75. The main causative agents are viruses, such as influenza and respiratory syncytial virus (RSV). Viral LRIs in adults have historically received less attention. This study investigated the incidence of RSV and influenza in adult patients admitted to a referral hospital, as well as the clinical profile of these infections. Molecular testing was conducted on nasopharyngeal samples taken from a respiratory surveillance cohort comprising adult (15–59 years) and elderly (60+ years) hospitalized patients who tested negative for SARS-CoV-2, to determine the prevalence for influenza and RSV. Influenza was found to be less frequent among the elderly. The main symptoms of RSV infections were cough, fever, dyspnea, malaise, and respiratory distress, while headache, nasal congestion, a sore throat, and myalgia were most frequent in influenza. Elderly patients with RSV were not found to have more severe illness than adults under age 60, underscoring the importance of providing the same care to adults with this viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, SP, Brazil.
- Hospital de Base of São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.
- Hospital da Criança e Maternidade of São José do Rio Preto, São José do Rio Preto 15091-240, SP, Brazil.
- Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- Department of Preventive Medicine and Population Health, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- Center for Vector-Borne and Zoonotic Diseases, The University of Texas Medical Branch, Galveston, TX 77555, USA.
ORCID-Profile: Cassia F Estofolete, Cecília A Banho, Alice T Verro, Flora A Gandolfi, Livia Sacchetto, Nikos Vasilakis, Maurício L Nogueira
Förderung
- NIAID NIH HHS
- São Paulo Research Foundation (FAPESP)
- INCT Dengue Program
- Centers for Research in Emerging Infectious Diseases (CREID)
- National Institutes of Health (NIH/USA)
Zitieren
APA
Estofolete, C. F., Banho, C. A., Verro, A. T., Gandolfi, F. A., Dos Santos, B. F., Sacchetto, L., Marques, B. C., Vasilakis, N., & Nogueira, M. L. (2023). Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?. Viruses. https://doi.org/10.3390/v15091848
Vancouver
Estofolete CF, Banho CA, Verro AT, Gandolfi FA, Dos Santos BF, Sacchetto L, et al. Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?. Viruses. 2023. doi:10.3390/v15091848
BibTeX
@article{Estofolete2023,
author = {Estofolete, Cassia F and Banho, Cecília A and Verro, Alice T and Gandolfi, Flora A and Dos Santos, Bárbara F and Sacchetto, Livia and Marques, Beatriz de C and Vasilakis, Nikos and Nogueira, Maurício L},
title = {Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091848}
}
EUVIMED